Melatonin Post-Stroke: Safe Supplementation?

Melatonin is a neurohormone produced by the pineal gland and extra-pineal tissues, and is known for its role in regulating sleep and mood behaviour. It has been found to have neuroprotective effects in animal models of stroke, and is currently being investigated as a potential treatment for stroke patients.

Melatonin has been shown to reduce infarct size, brain edema, and oxidative damage in animal models of stroke. It also has anti-inflammatory and antiapoptotic properties, and can reduce cerebral inflammation and improve electrophysiological and behavioural performance. Its ability to cross the blood-brain barrier, along with its low toxicity, make it a promising candidate for stroke treatment.

However, there is a lack of clinical evidence to support the use of melatonin in stroke patients. Further clinical research is needed to determine the optimal dosage and timing of melatonin administration for stroke treatment.

Melatonin is a neurohormone that can be used to limit the damage caused by a stroke, not repair it

Melatonin can be used to limit the damage caused by a stroke due to its anti-inflammatory, antiapoptotic, and neuroprotective properties. It binds the free radicals released by the brain after a stroke, removing them so no further damage should occur. Acting as an anti-inflammatory, melatonin helps to reduce brain cell death due to brain infection while lessening the damage in brain tissue which has suffered a lack of blood flow. Studies have also found that low melatonin levels are associated with a higher stroke risk.

Melatonin can also reduce harmful LDL cholesterol levels, which can help to lower blood pressure, which is useful for stroke prevention. Additionally, melatonin increases neuroplasticity, the ability of a brain nerve cell to begin doing the activities the dead or damaged brain cell used to do before the stroke.

Melatonin has been found to provide useful benefits for people suffering from dementia and Alzheimer's disease. It is a sleep-inducing hormone, present in higher levels during the evening, and it can be taken as a supplement.

Melatonin is an antioxidant that binds to free radicals released by the brain after a stroke

Melatonin is a neurohormone produced by the pineal gland and other organs such as the retina, gut, bone marrow, and kidney. It is a potent antioxidant and free radical scavenger that can directly detoxify reactive oxygen and nitrogen species.

Melatonin is a promising neuroprotective agent for stroke patients. It can cross the blood-brain barrier and has a low toxicity profile. Its anti-inflammatory capabilities are related to the inhibition of microglial activation and the reduction of pro-inflammatory cytokine concentrations. It also has antiapoptotic properties and can regulate calcium levels.

Melatonin can bind the free radicals released by the brain after a stroke, removing them so no further damage should occur. It can also reduce brain cell death due to brain infection and lessen the damage in brain tissue which has suffered a lack of blood flow. Studies have found that low melatonin levels are associated with higher stroke risk, making it even more beneficial before a stroke occurs, as well as after.

Melatonin is an anti-inflammatory that helps to reduce brain cell death and lessens the damage in brain tissue which has suffered a lack of blood flow

Melatonin is a neurohormone secreted by the pineal gland and is a well-known antioxidant. It is both lipid- and water-soluble and can readily cross the blood-brain barrier. Melatonin has been shown to reduce infarct volume, oedema, and oxidative damage and improve electrophysiological and behavioural performance. It also exerts antiapoptotic, antiexcitotoxic, and anti-inflammatory effects and promotes mitochondrial functions in animals with cerebral ischaemia.

Melatonin has been found to reduce oxidative stress, promote mitochondrial functions, decrease excitotoxicity, suppress inflammation and diminish apoptosis. It also reduces the expression of iNOS, which is an enzyme that produces nitric oxide, a free radical that can cause cell damage. Melatonin also inhibits the production of pro-inflammatory cytokines and the expression of adhesion molecules.

Melatonin is a direct and indirect antioxidant, scavenging free radicals and increasing the activity of antioxidant enzymes. It also suppresses nitric oxide production by reducing nNOS synthesis in neurons and abolishing iNOS expression in macrophages. It also stimulates the activity of NADH-coenzyme Q reductase and cytocrhome c oxidase in the electron transport chain of mitochondria, reducing electron leakage and free radical production and maintaining normal adenosine triphosphate (ATP) production.

Melatonin can reduce harmful LDL cholesterol levels, which can help to lower blood pressure

Melatonin is a neurohormone secreted by the pineal and extra pineal tissues responsible for various physiological processes like sleep and mood behaviour. Melatonin has been implicated in various neurological diseases because of its antioxidative, antiapoptotic, and anti-inflammatory properties. Melatonin has been found to have a positive impact on reducing harmful LDL cholesterol levels, which can help to lower blood pressure.

Melatonin is a naturally occurring antioxidant that can cross the blood-brain barrier and has been shown to have protective effects against cerebral ischemia in animal models. In addition to its potent antioxidant properties, melatonin exerts antiapoptotic, antiexcitotoxic, and anti-inflammatory effects and promotes mitochondrial functions in animals with cerebral ischemia.

Melatonin supplementation has been associated with improvements in blood lipids, including a significant reduction in triglycerides and total cholesterol levels. However, the current evidence from randomised controlled trials is inconsistent, and further studies are needed to determine the benefits of melatonin on the lipid profile.

Melatonin has been found to have a neuroprotective effect in various models of brain injury, including traumatic brain injury and spinal cord injury. It has been shown to reduce infarct volume, oedema, and oxidative damage and improve electrophysiological and behavioural performance in animal models of stroke. Melatonin's neuroprotective mechanisms include reducing oxidative damage, inhibiting apoptosis, regulating Ca2+ levels, and exerting anti-inflammatory effects.

The primary therapeutic strategy in treating cerebral ischemia is to restore blood flow as soon as possible to preserve neural tissues and prevent further damage. Melatonin has been proposed as an ideal therapeutic agent for this purpose due to its antioxidant properties, safety profile, and ability to cross the blood-brain barrier.

In summary, melatonin has been found to have beneficial effects in reducing harmful LDL cholesterol levels and lowering blood pressure. However, more research is needed to fully understand the effects of melatonin on the lipid profile and its potential therapeutic benefits in stroke patients.

Melatonin increases neuroplasticity, which is the ability of a brain nerve cell to begin doing the activities of a dead or damaged brain cell

Melatonin is a neurohormone secreted by the pineal gland and is known to regulate the sleep cycle by controlling the circadian rhythm. It has been found to have protective effects on neurons, especially against oxidative stress, and can be used as a target for the development of various neurological diseases. Melatonin has been found to have neuroprotective effects and affects neuroplasticity, thus indicating potential antidepressant properties.

Neuroplasticity is the ability of the brain to change and adapt due to experience. It is an umbrella term referring to the brain's ability to change, reorganize, or grow neural networks. This can involve functional changes due to brain damage or structural changes due to learning.

Neuroplasticity can be broken down into two major mechanisms:

• Neuronal regeneration/collateral sprouting: This includes concepts such as synaptic plasticity and neurogenesis.
• Functional reorganization: This includes concepts such as equipotentiality, vicariation, and diaschisis.

Melatonin has been shown to have a role in both of these mechanisms. It has been found to increase the expression of antioxidant enzymes, such as superoxide dismutase and glutathione peroxidase, and to directly activate the intracellular antioxidant system, as well as chelating oxygen and nitrogen reactive species. It also plays a role in Ca2+ homeostasis and has been shown to protect mice against stroke by activating MT2 receptors, which reduces oxidative/inflammatory stress. Melatonin has also been found to promote dendrite formation by activating CaMKII and PKC and to increase the expression of antiapoptotic proteins like bcl-2 through SIRT1 pathways.

Frequently asked questions